| Low or High Botox Dilution for the Hemiplegic Gait? (NCT04630873) | University of Ioannina | 2020-11-20 |
| A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1903 (NCT04762407) | Hanmi Pharmaceutical Company Limited | 2020-11-20 |
| Efficacy of Preconditioned Adipose-Derived Stem Cells in Fat Grafting (NCT05610878) | University of the Punjab | 2020-11-20 |
| NeoVax With Nivolumab in Patients With Ovarian Cancer (NCT04024878) | Dana-Farber Cancer Institute | 2020-11-20 |
| Anti-CD19 Allo-CAR-T Cells for Relapsed B Cell Malignancies After HSCT (NCT04516551) | Xinqiao Hospital of Chongqing | 2020-11-20 |
| The Phase I/Phase II Clinical Study of VC004 in Patients With Localized Advanced/Metastatic Solid Tumors (NCT04614740) | Jiangsu vcare pharmaceutical technology co., LTD | 2020-11-20 |
| A Study of JNJ-75348780 in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) (NCT04540796) | Janssen Research & Development, LLC | 2020-11-20 |
| Office Based Transperineal Laser Ablation for Benign Prostatic Hyperplasia HYPERPLASIA (NCT04760483) | Urological Research Network, LLC | 2020-11-20 |
| Efficacy of Adipose Tissue Derived Stem Cells for the Treatment of Diabetic Foot Ulcers (NCT05610865) | University of the Punjab | 2020-11-20 |
| Reversal of Aspirin Antiplatelet Therapy With Cold Stored Platelets (NCT05111028) | Bloodworks | 2020-11-20 |
| A Study to Assess the Effect of Food With Fezolinetant in Healthy Female Participants (NCT04641260) | Astellas Pharma Global Development, Inc. | 2020-11-20 |
| Clinical Study of Targeting CD19 and CD22 Chimeric Antigen Receptor T Lymphocytes in the Treatment of Recurrent or Refractory B Cell Non-Hodgkin Lymphoma (NCT04626908) | He Huang | 2020-11-20 |
| Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease (NCT04519671) | Anthony Lembo | 2020-11-19 |
| Ascending Dose Study of the Safety and Tolerability of REGN6490 in Healthy Volunteers (NCT04616079) | Regeneron Pharmaceuticals | 2020-11-19 |
| Advanced Lung Tumor Treated by Osimertinib Plus Anlotinib (NCT04770688) | Shanghai Chest Hospital | 2020-11-19 |
| Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer (NCT04331067) | Washington University School of Medicine | 2020-11-19 |
| Study to Investigate the Potential Drug-Drug Interaction Between ZSP1273 and Oseltamivir (NCT05108051) | Guangdong Raynovent Biotech Co., Ltd | 2020-11-19 |
| A Trial to Evaluate Safety and Efficacy of RP-L401-0120 in Subjects With Infantile Malignant Osteopetrosis (NCT04525352) | Rocket Pharmaceuticals Inc. | 2020-11-19 |
| Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies (NCT04672434) | Symphogen A/S | 2020-11-19 |
| Hypofractionated Accelerated Pelvic Nodal Radiotherapy (GCC 2048) (NCT04486755) | University of Maryland, Baltimore | 2020-11-19 |
| A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy (NCT04445220) | Sentien Biotechnologies, Inc. | 2020-11-19 |
| Bioequivalence Study to Compare Two Tablets of Ivermectin Tablets (3 mg Ivermectin) Versus Two Tablets of Stromectol ® Tablets (3 mg Ivermectin), in Healthy Subjects Under Fasting Conditions (NCT05082753) | Humanis Saglık Anonim Sirketi | 2020-11-19 |
| PET/MRI in the Diagnosis of Pediatric Chronic Pain (NCT04435821) | Stanford University | 2020-11-19 |
| Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations (NCT04603001) | Eli Lilly and Company | 2020-11-19 |
| Study to Evaluate the Safety and Pharmacokinetics of Efmarodocokin Alfa in Combination With Standard of Care in Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (NCT04539470) | Genentech, Inc. | 2020-11-19 |
| A Synthetic MVA-based SARS-CoV-2 Vaccine, GEO-CM04S1, for the Prevention of COVID-19 Infection (NCT04639466) | GeoVax, Inc. | 2020-11-19 |
| Study of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL) (NCT04607772) | Karyopharm Therapeutics Inc | 2020-11-18 |
| Study of the Safety, Tolerability, and Pharmacokinetics of REGN6490 in Healthy Japanese Adult Volunteers (NCT04616105) | Regeneron Pharmaceuticals | 2020-11-18 |
| A Trial of AK104 Plus Anlotinib in NSCLC (NCT04646330) | Akeso | 2020-11-18 |
| Initiation of Acid Suppression Therapy Prospective Outcomes for Laryngomalacia (NCT04614974) | Reema Padia | 2020-11-18 |
| Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies (NCT04681105) | City of Hope Medical Center | 2020-11-18 |
| Palbociclib and Binimetinib in Advanced Triple Negative Breast Cancer (NCT04494958) | Fundacion Oncosur | 2020-11-18 |
| First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS) (NCT04483297) | Asahi Kasei Therapeutics Corporation | 2020-11-18 |
| Safety, Tolerability and PK of Ensovibep (MP0420 - a New Candidate With Potential for Treatment of COVID-19) (NCT04870164) | Molecular Partners AG | 2020-11-18 |
| Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor in Patients With Advanced Solid Tumor (NCT04648254) | Qurient Co., Ltd. | 2020-11-18 |
| A Study of Anti-PD-L1 Antibody in Neoadjuvant Chemotherapy of Esophageal Squamous Cell Carcinoma. (NCT04460066) | Lee's Pharmaceutical Limited | 2020-11-18 |
| Study of SNX281 in Subjects With Advanced Solid Tumors and Lymphoma (NCT04609579) | Stingthera, Inc. | 2020-11-18 |
| A First-in-human Single and Repeated Dose Escalation Study of SAR442501 in Healthy Adults Subjects (NCT05846009) | Sanofi | 2020-11-18 |
| Drug-drug Interactions and Safety Among JP-1366, Amoxicillin, and Clarithromycin in Healthy Volunteers (NCT05194046) | Onconic Therapeutics Inc. | 2020-11-18 |
| FS120 Phase 1/1b Study in Patients With Advanced Malignancies (NCT04648202) | invoX Pharma Limited | 2020-11-18 |
| Study to Investigate Safety, Tolerability, PK and PD Response of SLN360 in Subjects With Elevated Lipoprotein(a) (NCT04606602) | Silence Therapeutics plc | 2020-11-18 |
| First in Human Study to Test the Safety and Preliminary Efficacy of PPSGG in Patients With Anti-MAG Neuropathy (NCT04568174) | Polyneuron Pharmaceuticals AG | 2020-11-17 |
| Multi-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DDO-3055 Tablets in Patients With Anemia of Non-dialysis Chronic Kidney Diseases. (NCT04470063) | Jiangsu HengRui Medicine Co., Ltd. | 2020-11-17 |
| KRT-232 in Combination With TL-895 for the Treatment of R/R MF and KRT-232 for the Treatment of JAKi Intolerant MF (NCT04640532) | Kartos Therapeutics, Inc. | 2020-11-17 |
| Relapse in Previously Irradiated Prostate Bed : Stereotactic Ablative Reirradiation Potentiated by Metformin (NCT04536805) | Institut Cancerologie de l'Ouest | 2020-11-17 |
| Study of GS-0189 (Formerly FSI-189) as Monotherapy and in Combination With Rituximab in Participants With Relapsed/Refractory Non-Hodgkin Lymphoma (NCT04502706) | Gilead Sciences | 2020-11-17 |
| Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients (NCT04379518) | Roswell Park Cancer Institute | 2020-11-17 |
| Assessment of Safety, Tolerability, Immunogenicity, and Pharmacokinetics of AZD3427 (NCT04630067) | AstraZeneca | 2020-11-17 |
| Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia. (NCT04299048) | Pfizer | 2020-11-17 |
| A Single and Multiple Ascending Dose Study of Niclosamide in Healthy Volunteers (NCT04705415) | NeuroBo Pharmaceuticals Inc. | 2020-11-17 |
| Intradermal (ID) BOTOX in the Treatment of Facial Fine Lines (NCT04631588) | Allergan | 2020-11-16 |
| Study to Evaluate and Compare the PK Profiles of Abaloparatide-SC and Abaloparatide-sMTS in a Cohort of Healthy Men and Healthy Women. (NCT04663464) | Radius Health, Inc. | 2020-11-16 |
| A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-845 (NCT04673682) | Chong Kun Dang Pharmaceutical | 2020-11-16 |
| Angiographic Delivery of AD-MSC for Ulcerative Colitis (NCT04312113) | Mayo Clinic | 2020-11-16 |
| A Placebo-controlled Phase 1 Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-1014-6470 in Healthy Subjects (NCT04608513) | Idorsia Pharmaceuticals Ltd. | 2020-11-16 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Pozelimab in Combination With Cemdisiran in Healthy Adult Volunteers (NCT04601844) | Regeneron Pharmaceuticals | 2020-11-16 |
| Study to Evaluate and Compare the Bioequivalence of Two Abaloparatide-sMTS Treatments in Healthy Women. (NCT04936984) | Radius Health, Inc. | 2020-11-16 |
| Evaluating the Pharmacokinetic Interaction Between AD-2101 and AD-2102 (NCT04600284) | Addpharma Inc. | 2020-11-16 |
| Safety, Activity and Cell Kinetics of CYAD-211 in Patients With Relapsed or Refractory Multiple Myeloma (NCT04613557) | Celyad Oncology SA | 2020-11-16 |
| AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension (NCT04499248) | AbbVie | 2020-11-16 |
| A Study to Test the Safety and Tolerability of Long-term UCB0107 Administration in Study Participants With Progressive Supranuclear Palsy (NCT04658199) | UCB Biopharma SRL | 2020-11-16 |
| A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Repaglinide or Bupropion in Advanced Solid Tumor Subjects (NCT04457180) | Jiangsu HengRui Medicine Co., Ltd. | 2020-11-16 |
| Developing Clinical Tools to Communicate Genetic Risk for Individuals Who Are Clinical High Risk for Psychosis (NCT04325568) | New York University | 2020-11-16 |
| Imvamune Vaccine for the Treatment of Non-melanoma Skin Cancer (NCT04410874) | Ivan Litvinov | 2020-11-16 |
| A Study to Assess How Radium-223 Distributes in the Body of Patients With Prostate Cancer Which Spread to the Bones (NCT04521361) | Bayer | 2020-11-16 |
| A Clinical Study of the HIV Drug CPT31 in Healthy Volunteers (NCT04672083) | Navigen, Inc. | 2020-11-16 |
| Pre-emptive Pregabalin on Attenuating Maternal Anxiety And Stress Response To Intubation During Caesarean Section (NCT04622202) | Zagazig University | 2020-11-15 |
| DAW2020 on OSA Endotypic Traits (NCT04538755) | Brigham and Women's Hospital | 2020-11-15 |
| Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies (NCT04551963) | BeiGene | 2020-11-15 |
| BOL-DP-o-05 as an Add-On Treatment of Subjects With Newly Diagnosed Type 1 Diabetes Mellitus (NCT04102202) | Breath of Life International Pharma Ltd | 2020-11-15 |
| Stellate Ganglion Blockade in Corona Virus 2019 (COVID-19) Positive Patients (NCT04445337) | University of Nebraska | 2020-11-15 |
| Pharmacokinetic Profile of Voriconazole Inhalation Powder in Adult Subjects With Asthma (NCT04576325) | TFF Pharmaceuticals, Inc. | 2020-11-15 |
| Mass Balance and Biotransformation of [14C]HSK7653 in Human (NCT04540016) | Sichuan Haisco Pharmaceutical Group Co., Ltd | 2020-11-15 |
| Allogeneic PB103 (NK Cells) Therapy in Non-small Cell Lung Cancer (NSCLC) Patients (NCT04616209) | Precision Biotech Taiwan Corp. | 2020-11-15 |
| Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients (NCT04535856) | Ina-Respond | 2020-11-14 |
| The Effect of a Mediterranean Diet Intervention on Cancer-related Fatigue and Mitochondrial Function During Chemotherapy (NCT04534738) | University of Rochester | 2020-11-14 |
| N-Acetyl Glucosamine as Therapeutic Intervention for Coronavirus Disease-19 (COVID-19) (NCT04706416) | Quantinosis.ai LLC | 2020-11-14 |
| Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 Patients (NCT04472585) | Sohaib Ashraf | 2020-11-14 |
| A Trail of CDK4 / 6 Inhibitor and MEK Inhibitor in the Treatment of Metastatic Digestive System Tumors (NCT04615312) | Henan Cancer Hospital | 2020-11-14 |
| Safety Stem Cells in Spinal Cord Injury (NCT04205019) | Neuroplast | 2020-11-14 |
| A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19 (NCT04646044) | Nektar Therapeutics | 2020-11-13 |
| A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 (NCT04673695) | Chong Kun Dang Pharmaceutical | 2020-11-13 |
| A Study in Healthy Japanese Men to Test How Different Doses of BI 1323495 Are Tolerated and How Itraconazole Influences the Amount of BI 1323495 in the Blood (NCT04619251) | Boehringer Ingelheim | 2020-11-13 |
| Bioequivalence Study of Favipiravir 200 mg Film Tablet (Pharma Plant, Turkey) Under Fasting Conditions (NCT04651959) | Pharma Plant | 2020-11-13 |
| Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation (NCT04005469) | Rhode Island Hospital | 2020-11-13 |
| Absolute Bioavailability and ADME Study of Savolitinib in Healthy Male Subjects (NCT04675021) | AstraZeneca | 2020-11-13 |
| Fluorescence Molecular Endoscopy and Molecular Fluorescence-guided Surgery in Locally Advanced Rectal Cancer (NCT04638036) | University Medical Center Groningen | 2020-11-13 |
| Hepatic Intra-Arterial Administration of Ipilimumab in Combination With Intra-venous Nivolumab for Advanced Hepatocellular Carcinoma (NCT04823403) | Gustave Roussy, Cancer Campus, Grand Paris | 2020-11-13 |
| A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer (NCT04577833) | Janssen Research & Development, LLC | 2020-11-13 |
| Cultured Autologous Oral Mucosa Epithelial Sheet for the Treatment of Bilateral Limbal Stem Cell Deficiency (NCT03949881) | Hospices Civils de Lyon | 2020-11-13 |
| Glucagon Receptor Inhibition to Enable Breast Cancer Patients to Benefit From PI3K Inhibitor Therapy (REMD-477) (NCT04330625) | Duke University | 2020-11-13 |
| Study on Safety and Efficacy of NMS-01940153E in Adult Patients With Unresectable Hepatocellular Carcinoma (HCC) Previously Treated With Systemic Therapy (NCT05630937) | Nerviano Medical Sciences | 2020-11-13 |
| Pharmacokinetics of Enasidenib (CC-90007) in Participants With Mild, Moderate and Severe Hepatic Impairment (NCT04573582) | Celgene | 2020-11-13 |
| Efficacy and Safety of Rifaximin With NAC in IBS-D (NCT04557215) | Cedars-Sinai Medical Center | 2020-11-13 |
| First-in-Human Study of the SHP2 Inhibitor BBP-398 in Patients With Advanced Solid Tumors (NCT04528836) | Navire Pharma Inc., a BridgeBio company | 2020-11-12 |
| A Study of ZN-c5 and Abemaciclib in Participants With Breast Cancer (NCT04514159) | Zeno Alpha Inc. | 2020-11-12 |
| A Trial of HRS4800 Tables in Healthy Male Subjects (NCT04573036) | Atridia Pty Ltd. | 2020-11-12 |
| EUS Guided Portal-systemic Pressure Gradient Measurement (NCT04633356) | Chinese University of Hong Kong | 2020-11-12 |
| Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis (NCT04598919) | National Jewish Health | 2020-11-12 |
| A Trial of Anlotinib Combined With Concurrent Chemoradiotherapy in Patients With Unresectable Stage III Non-small Cell Lung Cancer (NCT04958993) | Shandong Cancer Hospital and Institute | 2020-11-12 |